Molecule
PrivateLast Round
Strategic
Dec 11, 2023
Total Funding Raised
$13.7M
Company Overview
Molecule operates in Crypto & Web3 and is based in Switzerland. Its latest recorded funding round was a Strategic round in December 2023.
Molecule is a biotechnology and web3 company that operates a decentralized marketplace to connect researchers with funding for scientific and drug development projects.
Sector
Crypto & Web3
Verticals
Biotechnology, Blockchain Infrastructure, Drug Discovery, Tokenization, DAOs
Business Model
B2B
Customer Profile
Marketplace Commission, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Molecule Comparables
Compare Molecule with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bio Protocol | 88% | |
| AthenaBIO | 81% | |
| LabDAO | 77% |
For institutional investors. Book with your work email.
Molecule Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 11, 2023 | ||||
| Seed | Jun 27, 2022 | ||||
| Pre Seed | Jan 31, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Molecule Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Seed |
| Backed VC | Seed |
| Inflection | Pre Seed, Seed |
| ID Theory | Pre Seed, Seed |
| First Principles | Pre Seed, Seed |
| L1 Digital | Seed |
| Orange DAO | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2025
Added ResearchHub, a scientific research startup, as a customer.
- Sep 30, 2025
Added Biome as a new customer.
For institutional investors. Book with your work email.
Molecule Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Molecule's valuation, stock price, and market status.
Is Molecule a public or private company?
Molecule is a private company.
What is the current stock price of Molecule?
Molecule is a private company, so its shares have no public market price. Caplight tracks Molecule's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Molecule worth (valuation)?
Valuation information for Molecule is not publicly available.
Can I buy Molecule stock?
Molecule shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Molecule's last funding round?
Molecule's most recent funding round was Strategic on December 11, 2023.
Who are the main investors in Molecule?
Key investors in Molecule include Northpond Ventures, Sora Ventures, Lunar Ventures.
Will Molecule IPO soon?
No public IPO plans have been announced for Molecule.
How can I track Molecule secondary market activity?
Caplight tracks bids, offers, and trades in Molecule's shares on secondary markets.